Loading...
CSRP2 Polyclonal Antibody

30961

CSRP2 Polyclonal Antibody

CSRP2 Polyclonal Antibody (catalogue number 30961) is a rabbit-derived primary antibody validated for Western blot, reactive with Human, Mouse samples. It targets Cysteine and glycine-rich protein 2 (CSRP2): Drastically down-regulated in response to PDGF-BB or cell injury, that promote smooth muscle cell proliferation and dedifferentiation. Supplied in 2 pack sizes, from 50ul at ₪1,260.38 to 100ul at ₪1,790.64; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human, Mouse
Applications
Western blot
UniProt ID
Q16527
Gene
CSRP2
Target organism
Homo sapiens
Catalogue number
30961
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Cysteine and glycine-rich protein 2 (CSRP2) · Homo sapiens

Drastically down-regulated in response to PDGF-BB or cell injury, that promote smooth muscle cell proliferation and dedifferentiation. Seems to play a role in the development of the embryonic vascular system

Subcellular location: Nucleus

Tissue specificity: Highly expressed in the aorta, but not in heart and skeletal muscle

Sequence length: 193 aa · 20954 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.